RMD · Resmed Inc

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $202.410 - $204.160. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $216.772 - $219.700. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $192.605 - $194.715. The price reported above reflects the weighted average sale price.

Includes 32.671 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.

Includes 66.0288 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $206.45 - $210.47. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $222.5643 - $227.96. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $246.83 - $253.09. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $270.25 - $276.35. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $246.801 - $249.969. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $249.63 - $255.775. The price reported above reflects the weighted average sale price.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

Represents date options first become exercisable. Options vest 1/3 per year.

The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.

The transaction was conducted under a Rule 10b5-1 plan adopted on August 18, 2025.

Represents the date on which options first become exercisable. The options vest on the earlier of (i) November 11, 2026, or (ii) the date of the first annual meeting of stockholders of the Company following the Grant Date.

Represents the date on which options first become exercisable. The options vest on the earlier of (i) November 11, 2026, or (ii) the date of the first annual meeting of stockholders of the Company following the Grant Date.

Represents the date on which options first become exercisable. The options vest in three equal annual installments commencing on November 11, 2026.

Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.

Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.

Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.

Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.